Opposing effects of ERK and p38 MAP kinases on HeLa cell apoptosis induced by dipyrithione

被引:0
作者
Fan, Yumei
Chen, Hui
Qiao, Bo
Luo, Lan
Ma, Hsiaoyen
Li, Heng
Jiang, Jihong
Niu, Dezhong
Yin, Zhimin [1 ]
机构
[1] Nanjing Normal Univ, Jiangsu Prov Key Lab Mol & Med Biotechnol, Coll Life Sci, Nanjing 210097, Peoples R China
[2] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Sch Life Sci, Nanjing 210008, Peoples R China
[3] Xuzhou Normal Univ, Jiangsu Prov Key Lab Mol & Med Biotechnol, Coll Life Sci, Xuzhou 221009, Peoples R China
关键词
anti-tumor; apoptosis; caspase-3; ERK; p38; PTS2;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dipyrithione (2, 2'-dithiobispyridine-1, V-dioxide, PTS2), a pyrithione derivate, is highly bactericidal and fungicidal. In this study we examined its apoptotic effect on HeLa cells. PTS2 induced HeLa cell death in a dose and time dependent manner. ERK1/2 and p38 were markedly activated, but little JNK1/2 activation was detected. Suppression of p38 activation by SB203580 reduced the extent of apoptosis of the HeLa cells and also prevented induction of p21, release of cytochrome c, and cleavage of caspase-3 and PARP. Inhibition of ERK1/2 with PD98059 increased apoptosis, indicating that ERK1/2 activation has an anti-apoptotic effect on PTS2-induced HeLa cell apoptosis. PTS2 also inhibited murine sarcoma 180 and hepatoma 22 tumor growth in an animal tumor model. Our findings indicate that PTS2 possesses anti-tumor activity, that caspase-3 and poly (ADPribose) polymerase (PAR-P) are involved in PTS2-induced HeLa cell apoptosis and that ERK1/2 and p38 have opposing effects on this apoptosis.
引用
收藏
页码:30 / 38
页数:9
相关论文
共 52 条
  • [1] High-intensity p38 kinase activity is critical for p21cip1 induction and the antiproliferative function of Gi protein-coupled receptors
    Alderton, F
    Humphrey, PPA
    Sellers, LA
    [J]. MOLECULAR PHARMACOLOGY, 2001, 59 (05) : 1119 - 1128
  • [2] Morphological and biochemical characterization and analysis of apoptosis
    Allen, RT
    Hunter, WJ
    Agrawal, DK
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 1997, 37 (04) : 215 - 228
  • [3] An WW, 2004, ACTA PHARMACOL SIN, V25, P1502
  • [4] SDF-1 synergistically enhances IL-3-induced activation of the Raf-1/MEK/Erk signaling pathway through activation of Rac and its effector Pak kinases to promote hematopoiesis and chemotaxis
    Arai, A
    Jin, A
    Yan, WH
    Mizuchi, D
    Yamamoto, K
    Nanki, T
    Miura, O
    [J]. CELLULAR SIGNALLING, 2005, 17 (04) : 497 - 506
  • [5] Death receptors: Signaling and modulation
    Ashkenazi, A
    Dixit, VM
    [J]. SCIENCE, 1998, 281 (5381) : 1305 - 1308
  • [6] Pathways governing G1/S transition and their response to DNA damage
    Bartek, J
    Lukas, J
    [J]. FEBS LETTERS, 2001, 490 (03) : 117 - 122
  • [7] The role of MAPK pathways in the action of chemotherapeutic drugs
    Boldt, S
    Weidle, UH
    Kolch, W
    [J]. CARCINOGENESIS, 2002, 23 (11) : 1831 - 1838
  • [8] Distinct requirements for p38α and c-jun N-terminal kinase stress-activated protein kinases in different forms of apoptotic neuronal death
    Cao, J
    Semenova, MM
    Solovyan, VT
    Han, JH
    Coffey, ET
    Courtney, MJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (34) : 35903 - 35913
  • [9] A key role for caspase-2 and caspase-3 in the apoptosis induced by 2-chloro-2′-deoxy-adenosine (Cladribine) and 2-chloro-adenosine in human astrocytoma cells
    Ceruti, S
    Beltrami, E
    Matarrese, P
    Mazzola, A
    Cattabeni, F
    Malorni, W
    Abbracchio, MP
    [J]. MOLECULAR PHARMACOLOGY, 2003, 63 (06) : 1437 - 1447
  • [10] ERK1/2 and p38 pathways are required for P2Y receptor-mediated prostate cancer invasion
    Chen, L
    He, HY
    Li, HM
    Zheng, J
    Heng, WJ
    You, JF
    Fang, WG
    [J]. CANCER LETTERS, 2004, 215 (02) : 239 - 247